Author

Alison Inglis

Amgen (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex Golkar· 1 shared Amine SadokiD· 1 shared Bo ZhouiD· 1 shared Jaeki MiniD· 1 shared Jianzhong HuiD· 1 shared Kate Smither· 1 shared Kaylee ChoiiD· 1 shared Kelvin Frank ChoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alex Golkar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Reprogramming VHL with molecular glues enables selective degradation of caspase-2

Jianzhong Hu, Weixian Deng, Shu Ou, Alex Golkar, Alison Inglis, Kate Smither, Shiqian Li, Kui Chen, Kelvin Frank Cho, Sung Jun Bae, Stephan Zech, Kaylee Choi, Willem den Besten, Stephanie Voß, Olivier Bedel, , Jaeki Min

This study develops VHL molecular glues that selectively degrade caspase-2, expanding the substrate range of VHL-based degraders and providing tools to study caspase-2's role in apoptosis and stress.

bioRxiv · Aug 17, 2026 · PreprintBiochemistry